Our Pricing

Wegovy Discount Code UK: Complete Stock Availability Guide

Published on: June 03, 2026

Searching for a wegovy discount code uk online pharmacy with guaranteed stock? Cured Pharmacy offers the discount code WEIGHTLOSSNEW for £79.00 off your first order, with all Wegovy doses currently in stock from £79.00. Our UK-registered clinical team provides free online consultations, and every pen is genuine UK-licensed semaglutide dispensed by our GPhC-registered pharmacy.

How to Use Your Wegovy Discount Code WEIGHTLOSSNEW

Applying your Wegovy discount code at Cured Pharmacy is straightforward. After completing your free clinical assessment with our UK prescriber, you'll proceed to checkout where the code WEIGHTLOSSNEW automatically applies £79.00 off your first Wegovy order. This discount works across all available doses, from the 0.25mg starter pen through to the 2.4mg maintenance dose.

Unlike other promotions that exclude certain products or require minimum spend thresholds, our discount code applies to single-pen purchases and multi-month supplies alike. The £79.00 saving is deducted before payment, so you see your final price upfront—no hidden fees or surprise charges at delivery. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every discounted order meets the same rigorous dispensing standards as full-price prescriptions.

All Wegovy Doses Currently In Stock at Cured Pharmacy

Wegovy follows a structured dose escalation schedule recommended by the MHRA. You begin with 0.25mg weekly for four weeks, then increase to 0.5mg, 1mg, 1.7mg, and finally 2.4mg—the maintenance dose used in the pivotal STEP trials [1]. Each step typically lasts four weeks, allowing your body to adapt and minimising gastrointestinal side effects.

Having all doses in stock matters clinically. Interrupting your titration schedule or missing doses can reduce efficacy and increase side effects when you restart [2]. At Cured Pharmacy, we track your prescription timeline and send reminders before you need your next dose strength, ensuring seamless progression through the treatment programme.

Stock Availability Across the Dose Range

We maintain consistent stock of all five Wegovy dose strengths: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg. This complete range availability means your treatment won't be interrupted by supply gaps when you need to titrate to the next dose level. Many patients have experienced frustrating delays with other suppliers during the national semaglutide shortage, but our direct pharmaceutical partnerships ensure reliable UK stock.

Wegovy Clinical Evidence: What the STEP Trials Show

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone regulating appetite and blood sugar. In the landmark STEP 1 trial, adults with obesity achieved an average 14.9% body weight reduction over 68 weeks on the 2.4mg maintenance dose—significantly greater than the 2.4% seen with placebo [1]. Nearly one-third of participants lost 20% or more of their starting weight, results rarely seen with lifestyle intervention alone.

The STEP programme included over 4,500 participants across five major trials, demonstrating consistent efficacy across different populations [1][2]. STEP 2 specifically examined adults with type 2 diabetes, showing an average 9.6% weight loss alongside improved glycaemic control [2]. These trials established semaglutide 2.4mg as the most effective pharmacological weight management option licensed in the UK until the arrival of dual-agonist treatments.

Clinical trials also revealed Wegovy's cardiovascular benefits. Participants experienced reductions in blood pressure, inflammatory markers, and waist circumference—improvements that persist as long as treatment continues [3]. However, weight regain typically occurs if Wegovy is discontinued, which is why the MHRA licenses it for long-term chronic weight management rather than short-term use.

Wegovy Pricing: Transparent Costs at UK Online Pharmacies

Wegovy represents a significant monthly investment, which is why our discount code WEIGHTLOSSNEW and lowest price guarantee matter. Most patients remain on the 2.4mg maintenance dose long-term, so sustainable pricing affects treatment adherence. We've seen patients abandon effective therapy elsewhere due to unpredictable price increases or undisclosed fees added at checkout.

The UK market has seen considerable price variation for semaglutide weight loss treatments. Some providers charge premium rates for identical MHRA-licensed medication, whilst others advertise low prices but add consultation fees, delivery charges, or require expensive multi-month commitments. Our transparent model means the price you see for Wegovy is the price you pay—£79.00 with your discount code applied at checkout.

Understanding Your Total Treatment Cost

At Cured Pharmacy, Wegovy starts from £79.00 per four-week supply, with your exact price determined by the dose your UK prescriber recommends. We display all pricing before you complete your clinical assessment—no hidden consultation fees or surprise charges. The price includes your medication, prescriber review, and discreet home delivery across the UK.

Wegovy vs Alternative Weight Loss Treatments Available in the UK

Several prescription weight loss treatments are now licensed in the UK, each with distinct mechanisms and clinical profiles. Wegovy (semaglutide 2.4mg) activates GLP-1 receptors to reduce appetite and slow gastric emptying. Saxenda contains a lower-dose, daily-injection form of a related GLP-1 agonist called liraglutide. Orlistat works through a completely different pathway, blocking fat absorption in the gut rather than affecting appetite hormones.

Newer dual-agonist treatments activate both GLP-1 and GIP receptors, producing greater average weight loss in head-to-head trials compared to semaglutide alone [4]. These medications follow similar weekly injection schedules but typically cost more per month. Your UK prescriber will consider your medical history, weight loss goals, previous treatment responses, and budget when recommending the most appropriate option.

Injectable treatments like Wegovy generally produce greater weight loss than oral medications, but they require comfort with self-injection and come with a different side effect profile [1][3]. Some patients prefer the convenience and lower cost of tablets, whilst others prioritise maximum efficacy. There's no universally "best" choice—the right treatment depends on your individual circumstances, which is why our clinical assessment is personalised rather than automated.

How to Start Wegovy Treatment at Cured Pharmacy

Wegovy is a prescription-only medication in the UK, licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [1]. Your prescriber will verify you meet MHRA licensing criteria and check for contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Once approved, your Wegovy pens arrive in discreet, unbranded packaging via next-day courier. We include full patient information leaflets, injection technique guides, and access to our clinical support team if you have questions during treatment. Your prescriber will recommend follow-up intervals to monitor progress, adjust doses, and assess whether continuing therapy remains appropriate. Apply discount code WEIGHTLOSSNEW at checkout to Save £79.00 on your first order.

Your Clinical Assessment Process

Our free online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy. A UK-registered prescriber reviews every assessment individually—we never use automated approvals. If Wegovy is clinically appropriate and safe for you, your prescription is sent to our GPhC-registered pharmacy for same-day dispensing.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.